Schrodinger, Inc. ($SDGR)
Akinsanya Karen โ President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
31,599
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Akinsanya Karen |
|---|---|
| Title | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
| Transaction Date | Sep 17, 2026 |
| Expiration Date | Nov 29, 2028 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Sep 21, 2026 |
| Shares Purchased | 31,599 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 11,599 |
| Derivative | Derivative |
| Accession Number | 0001797672-26-000006 |
| Document | View SEC Filing |